FDA approves Glaxo cancer drug Votrient
Thursday, April 26, 2012 - 17:10
in Health & Medicine
WASHINGTON (Reuters) - U.S. regulators gave the nod to GlaxoSmithKline Plc's Votrient for a type of sarcoma on Thursday, following a positive advisory panel vote last month.